Ran Nussbaum Keros Therapeutics, Inc. (KROS) insider trading activity

KROS Quotes by TradingView

Ran Nussbaum Transaction History

Date Transaction Value Shares Traded Form
Nov 29 2022
SELL
Exercise of in-the-money or at-the-money derivatives securities
-
7,176
Nov 17 2020
BUY
Open market or private purchase
$3,000,000 $50.0 p/Share
60,000

Also insider at

PRVL
Prevail Therapeutics Inc.
Director
URGN
UroGen Pharma Ltd. Healthcare
Director
ELOX
Eloxx Pharmaceuticals, Inc. Healthcare
Director
RN

Ran Nussbaum

Princeton, NJ

Track Institutional and Insider Activities on KROS

Follow Keros Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KROS shares.

Notify only if

Insider Trading

Get notified when an Keros Therapeutics, Inc. insider buys or sells KROS shares.

Notify only if

News

Receive news related to Keros Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KROS